Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Veliparib|RADIATION: Standard radiation treatment
Sponsor: University of Michigan Rogel Cancer Center